KIMBERLY CHESS: Open Payments
NPI 1811318611 · MEADVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,997 in 174 payments from 15 companies in 2025. Trend: 2023 $2,136 · 2024 $2,241 · 2025 $2,997
Food & beverage: $2,997
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 53 | $764 |
| Alkermes, Inc. | 23 | $440 |
| Axsome Therapeutics, Inc. | 15 | $307 |
| Neurocrine BioSciences, Inc. | 12 | $295 |
| Vanda Pharmaceuticals Inc. | 11 | $213 |
| E.R. Squibb & Sons, L.L.C. | 15 | $202 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $178 |
| Lundbeck LLC | 10 | $173 |
| Otsuka America Pharmaceutical, Inc. | 13 | $170 |
| Sage Therapeutics, LLC | 3 | $61 |
Products named: UZEDY, AUSTEDO XR, ARISTADA, REXULTI, Auvelity, INGREZZA, COBENFY, FANAPT.
Industry payments across PA — which companies pay providers there.
